Our blog is regularly updated with industry news, company updates and insightful articles on new products and technologies authored by our in-house experts.
Our recent webinar, Sustainability by Design — Implementing Safe Solutions to Reduce Risks, was all about how the Teva api sustainability team ensures safe solutions are implemented from the earliest stages of API development all the way through to the commercial stage. Speakers included Franjo Yovich, Principal Pilot Engineer at the PLIVA site in Croatia;
In our latest podcast episode, we discuss environmental, social and governance (ESG) issues in pharma with Teva Pharmaceuticals experts, Itamar Schwartz and Adam Ajzensztejn! We deep-dive into why ESG is such a buzz word at the moment, what impact the pharma industry can actually have, and what makes Teva’s recent $5 billion sustainability-linked bond the
How does an API company source raw materials during early development stages? Where do the raw materials come from and how do we ensure our suppliers are reliable? It is all in a day’s work for Sharon Millrod, Senior Director, Head of Teva api Category Management, R&D Sourcing & Biologics and his global procurement R&D
There are two things that all 4 members of Teva api’s scientific support team have in common. One is that they are all chemists with strong backgrounds in R&D (we’re talking 60+ years combined!). And two, they all use their broad experiences and varied skillsets to support customers in the most holistic and well-rounded way
Our recent webinar, The Perfect Particle — Why Size Matters, was a deep-dive into the world of particle size. Particle size is one of the first physical properties that needs to be considered in an active pharmaceutical ingredient (API). During the webinar, Zohar De-Valenca, our Senior Manager of Manufacturing Sciences & Technology, spoke to our
